FLGT
Fulgent Genetics Inc
21.30$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -69.8% | -150.7% | – | +2,449.0% | +283.0% | -52.9% | -89.3% | -22.0% | -582.6% | |
| – | +193.4% | +103.5% | +47.7% | +25.2% | +16.5% | +17.5% | +271.5% | +196.8% | -20.0% | -4.6% | -3.2% | |
| – | – | -42.9% | -54.5% | +8.7% | +39.3% | +154.2% | +94.7% | +105.5% | +31.5% | +3.6% | -11.0% | |
| – | +65,423.1% | +22.6% | -72.9% | +31.4% | +13.5% | +106.8% | +162.4% | +229.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | +41.7% | -354.8% | – | |
| – | +187.3% | +80.4% | +41.4% | -47.1% | -58.3% | +2,988.8% | -34.7% | -21.3% | +18.3% | +81.5% | -44.0% | |
| – | +182.7% | +1,840.8% | -95.2% | – | -3,157.5% | +1,023.9% | +67.4% | -52.2% | – | -250.0% | – | |
| – | +0.0% | +0.0% | -100.0% | – | – | – | -72.3% | – | – | – | – | |
| – | +0.0% | -117.9% | – | -51.6% | -240.0% | +195.2% | +6,601.6% | +1,731.6% | -63.5% | -88.8% | +345.6% | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | -100.1% | +9,600.0% | +1,774.0% | -91.1% | -51.0% | |
| – | -12.5% | +1,208.3% | -101.7% | – | +191,733.3% | +807.9% | -67.3% | -190.3% | -38.1% | -89.9% | +205.1% | |
| – | – | +2,169.6% | -119.0% | – | +2,025.6% | +1,343.1% | +2.7% | -210.2% | – | -334.8% | – | |
| – | – | – | -752.4% | – | – | +2,301.8% | +394.4% | -54.4% | -98.0% | -501.5% | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.